BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19321257)

  • 1. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
    Deng H; Ravikumar TS; Yang WL
    Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.
    Deng H; Makizumi R; Ravikumar TS; Dong H; Yang W; Yang WL
    Exp Cell Res; 2007 Mar; 313(5):1033-44. PubMed ID: 17275810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
    Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
    Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
    Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
    J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Smad4 enhances proliferation and invasion of colorectal carcinoma HCT116 cells and up-regulates Id2.
    Shi Q; Zhong YS; Yao LQ; Li QL; Ren Z; Liu XP; Shi FM
    Mol Med Rep; 2012 Jan; 5(1):89-95. PubMed ID: 21956276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
    Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
    J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells.
    Kumagai T; Tomari K; Shimizu T; Takeda K
    Int J Mol Med; 2006 Feb; 17(2):285-91. PubMed ID: 16391828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of the BMP7-Smad4-Id2 signaling pathway in SW480 colorectal carcinoma cells.
    Shi Q; Zhong YS; Ren Z; Li QL; Zhou PH; Xu MD; Yao LQ
    Mol Med Rep; 2011; 4(4):627-31. PubMed ID: 21523323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
    Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
    Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
    Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
    Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway.
    Shen X; Qian L; Falzon M
    Exp Cell Res; 2004 Apr; 294(2):420-33. PubMed ID: 15023531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.